Search results for "OUTCOMES"

showing 10 items of 446 documents

Cohort Profile:The Socioeconomic Consequences in Adult Life After Childhood Cancer in Scandinavia (SALiCCS) Research Programme

2021

IntroductionThe growing number of survivors of childhood cancer, with many years of life ahead, demonstrates the increasing clinical and public health relevance of investigating the risks of social and socioeconomic impairment after a childhood cancer diagnosis and the life-saving treatment. To enrich understanding of the mental, social and socioeconomic difficulties that childhood cancer survivors may face during their life-course, identify particularly vulnerable survivors and overcome the limitations of previous research, we initiated the Socioeconomic Consequences in Adult Life after Childhood Cancer in Scandinavia (SALiCCS) research programme.MethodsThis Nordic cross-border research pr…

Cancer Researchchildhood cancer survivorsDenmark3122 CancersChildhood cancer610 Medicine & healthsocial and socioeconomic outcomes03 medical and health sciences0302 clinical medicine3123 Gynaecology and paediatrics360 Social problems & social servicesMedicine030212 general & internal medicineSocioeconomic statusRC254-282FinlandOriginal ResearchSwedenbusiness.industry1. No povertyNeoplasms. Tumors. Oncology. Including cancer and carcinogensregister-based research3. Good healthAdult lifeOncology030220 oncology & carcinogenesisCohortfamily lifebusinesssurvivorshipDemography
researchProduct

Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Pract…

2022

Digital health tools are increasingly being used in cancer care and may include electronic patient-reported outcome (ePRO) monitoring systems. We examined physicians’ perceptions of usability and clinical utility of a digital health tool (GIMEMA-ALLIANCE platform) for ePRO monitoring in the real-life practice of patients with hematologic malignancies. This tool allows for the collection and assessment of ePROs with real-time graphical presentation of results to medical staff. Based on a predefined algorithm, automated alerts are sent to medical staff. Participating hematologists completed an online survey on their experience with the platform. Of the 201 patients invited to participate betw…

Cancer Researchhematologydigital healthleukemialymphomaSettore MED/15patient-reported outcomes (PROs)digital health hematology leukemia lymphoma multiple myeloma patient-reported outcomes (PROs) quality of life symptomsmultiple myelomaOncologyquality of lifesymptomsdigital health; hematology; leukemia; lymphoma; multiple myeloma; patient-reported outcomes (PROs); quality of life; symptoms
researchProduct

The Porto European Cancer Research Summit 2021.

2021

Key stakeholders from the cancer research continuum met in May 2021 at the European Cancer Research Summit in Porto to discuss priorities and specific action points required for the successful implementation of the European Cancer Mission and Europe's Beating Cancer Plan (EBCP). Speakers presented a unified view about the need to establish high‐quality, networked infrastructures to decrease cancer incidence, increase the cure rate, improve patient's survival and quality of life, and deal with research and care inequalities across the European Union (EU). These infrastructures, featuring Comprehensive Cancer Centres (CCCs) as key components, will integrate care, prevention and research acros…

Cancer Researchmedicine.medical_specialty:Otros calificadores::Otros calificadores::/prevención & control [Otros calificadores]infrastructures for translational cancer researchDeclarationTranslational researchContext (language use)comprehensive cancer centresMeeting Reportclinical/prevention trials:profesiones sanitarias::medicina::medicina clínica::medicina de precisión [DISCIPLINAS Y OCUPACIONES]Translational Research Biomedicaloutcomes research:neoplasias [ENFERMEDADES]:Other subheadings::Other subheadings::/prevention & control [Other subheadings]cancer research/care/prevention continuumNeoplasmsPolitical scienceGeneticsmedicineHumansmedia_common.cataloged_instance:Health Occupations::Medicine::Clinical Medicine::Precision Medicine [DISCIPLINES AND OCCUPATIONS]Medicina personalitzadaPrecision MedicineEuropean unionRC254-282media_commongeographySummitgeography.geographical_feature_categoryHealth economics:Natural Science Disciplines::Science::Research::Biomedical Research [DISCIPLINES AND OCCUPATIONS]Neoplasms. Tumors. Oncology. Including cancer and carcinogensGeneral MedicineCancer MissionEuropescience policy:Neoplasms [DISEASES]Medicina - InvestigacióOncologyQuality of LifeCancer researchMolecular MedicineScience policyCàncer - PrevencióOutcomes research:disciplinas de las ciencias naturales::ciencia::investigación::investigación biomédica [DISCIPLINAS Y OCUPACIONES]
researchProduct

Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe

2020

Purpose Oncofertility focuses on providing fertility and endocrine-sparing options to patients who undergo life-preserving but gonadotoxic cancer treatment. The resources needed to meet patient demand often are fragmented along disciplinary lines. We quantify assets and gaps in oncofertility care on a global scale. Methods Survey-based questionnaires were provided to 191 members of the Oncofertility Consortium Global Partners Network, a National Institutes of Health–funded organization. Responses were analyzed to measure trends and regional subtleties about patient oncofertility experiences and to analyze barriers to care at sites that provide oncofertility services. Results Sixty-three res…

Cancer Researchmedicine.medical_specialtyReferralmedia_common.quotation_subjectBest practiceMEDLINEFertilitylcsh:RC254-282Cost EffectivenessFertilidade03 medical and health sciences0302 clinical medicineSupportive Care and Quality of LifeJournal ArticleQuality of CareMedicineFertility preservationmedia_commonOncofertilityEthicsMedicine(all)Response rate (survey)030219 obstetrics & reproductive medicinebusiness.industryHealth Services and OutcomesORIGINAL REPORTSlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensSupportive CarePolicy AnalysisWomen's cancers Radboud Institute for Health Sciences [Radboudumc 17]3. Good healthFertilityOncology030220 oncology & carcinogenesisFamily medicineScale (social sciences)Quality of Life/dk/atira/pure/researchoutput/pubmedpublicationtype/D016428business
researchProduct

Survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe

2018

Purpose In the accompanying article, “Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe,” we showed that specific fertility preservation services may not be offered at various sites around the world because of cultural and legal barriers. We assessed global and regional experiences as well as the legal status of third-party reproduction and adoption to serve as a comprehensive international data set and resource for groups that wish to begin oncofertility interventions. Methods We provide data on the legalities of third-party assisted reproductive technologies and other family-building options in the 28 oncofertility-practicing countries surveyed. R…

Cancer Researchmedicine.medical_specialtyResource (biology)fertility preservationPsychological interventionMEDLINEGlobeReproductive technologylcsh:RC254-28203 medical and health sciences0302 clinical medicineSupportive Care and Quality of LifeNeoplasmsSurveys and QuestionnairesOriginal ReportsJournal ArticlemedicineGlobal healthHumansFertility preservationReferral and ConsultationCancerOncofertility030219 obstetrics & reproductive medicineParentingbusiness.industryHealth Services and OutcomesPublic relationslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensWomen's cancers Radboud Institute for Health Sciences [Radboudumc 17]3. Good healthSurgerymedicine.anatomical_structureOncology030220 oncology & carcinogenesis/dk/atira/pure/researchoutput/pubmedpublicationtype/D016428businessreproductive medicine
researchProduct

Association of Arsenic Exposure With Cardiac Geometry and Left Ventricular Function in Young Adults

2019

Background: Arsenic exposure has been related to numerous adverse cardiovascular outcomes. The aim of this study was to investigate the cross-sectional and prospective association between arsenic exposure with echocardiographic measures of left ventricular (LV) geometry and functioning. Methods: A total of 1337 young adult participants free of diabetes mellitus and cardiovascular disease were recruited from the SHFS (Strong Heart Family Study). The sum of inorganic and methylated arsenic concentrations in urine (ΣAs) at baseline was used as a biomarker of arsenic exposure. LV geometry and functioning were assessed using transthoracic echocardiography at baseline and follow-up. Results: Mea…

Cardiac geometrymedicine.medical_specialtyVentricular functionbusiness.industrychemistry.chemical_element030204 cardiovascular system & hematology010501 environmental sciencesmedicine.disease01 natural sciences03 medical and health sciences0302 clinical medicineBlood pressurechemistryInternal medicineHeart failureCardiologyMedicineRadiology Nuclear Medicine and imagingYoung adultCardiology and Cardiovascular MedicinebusinessARSENIC EXPOSURECardiovascular outcomesArsenic0105 earth and related environmental sciencesCirculation: Cardiovascular Imaging
researchProduct

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right

2020

For almost half a century, cardiac transplant has been the only long-term treatment for patients with end-stage heart failure. Implantable left ventricular assist devices (LVADs) have emerged as a new treatment option for advanced heart failure as destination therapy for patients either too old or not suitable for transplant. A meta-analysis presenting head-to-head comparisons of cardiac transplant versus LVAD as destination therapy (LVAD-DT) found no difference in 1-year mortality rates between LVAD-DT and cardiac transplant (OR 1.49; 95% CI [0.48–4.66]; I2=82.8%). Moreover, a recent subanalysis from the Interagency Registry for Mechanically Assisted Circulatory Support found similar outco…

Cardiac transplantlcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyCardiomyopathy030204 cardiovascular system & hematologyoutcomes03 medical and health sciences0302 clinical medicineInternal medicineleft ventricular assist deviceDiseases of the circulatory (Cardiovascular) systemMedicine030212 general & internal medicineMyocardial infarctionStrokeHeart Failurebusiness.industryMortality rateAtrial fibrillationmedicine.diseaseequipment and supplieslcsh:RC666-701RC666-701Heart failureCirculatory systemCardiologydestination therapyCardiology and Cardiovascular MedicinebusinessDestination therapyEuropean Cardiology Review
researchProduct

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experienc…

2021

The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand for hospital admission. A systematic review of 29 comparative studies between in-hospital and outpatient treatment of Hematopoietic Stem Cell Transplantation, with no restriction by outpatient regime was conducted. This study aims to analyse the current evidence on the effects of the outpatient model on patient-centred outcomes, comparing both in-hospital and outpatient models for autologous and allogeneic HSCT using the Triple Aim framework: …

Cell Transplantationmedicine.medical_treatmentFeversHematopoietic stem cell transplantationHealth careOutpatientsMedicine and Health SciencesBlood and Lymphatic System ProceduresOutpatient clinicMultidisciplinaryMortality rateQRHematopoietic Stem Cell TransplantationHematopoietic stem cellResearch AssessmentHospitalsSurvival Ratemedicine.anatomical_structureSystematic reviewModels EconomicCosts and Cost AnalysisMedicineResearch Articlemedicine.medical_specialtyPatientsSystematic ReviewsDeath RatesScienceSurgical and Invasive Medical ProceduresHealth outcomesResearch and Analysis MethodsTransplantation AutologousDisease-Free SurvivalQuality of life (healthcare)Signs and SymptomsPopulation MetricsmedicineHumansTransplantation HomologousIntensive care medicineOutpatient ClinicsTransplantationInpatientsPopulation Biologybusiness.industryBiology and Life SciencesLength of StayHealth CareHealth Care FacilitiesQuality of LifeClinical MedicinebusinessStem Cell TransplantationPloS one
researchProduct

DESIGNING A TEACHER TRAINING PROGRAMME FOR CHARACTER EDUCATION: AN INTERNATIONAL PARTNERSHIP

2020

There is a need of innovative teacher training programmes for character education. This paper addresses three research questions: What are the challenges that a teacher training programme for character education should address? What are the learning outcomes that the programme should achieve? How should the programme be structured for supporting the achievement of those learning outcomes? Two regional authorities, three schools, three universities and a centre of teacher training from Latvia, Estonia and Spain created a strategic partnership for answering these research questions, using design-based implementation research. The results include six domains of learning outcomes and a programm…

Character educationStrategic partnershipPedagogyComputingMilieux_COMPUTERSANDEDUCATIONInternational partnershipContext (language use)Research questionsSociologyImplementation researchcharacter education instructional design; learning outcomes; teacher trainingTraining programmeSOCIETY. INTEGRATION. EDUCATION. Proceedings of the International Scientific Conference
researchProduct

Fostering Collaborative Governance in Chronic Disease Management Programs: A Dynamic Performance Management Approach

2020

Chronic diseases are the leading cause of disability and mortality in the world and represent a global health emergency due to the increase in frequency and complexity that has been occurring in recent years. The outcomes related to chronic care needs depend on the joint effort of a multi-provider, multi-disciplinary, and multi-professional service network, which operates along a clinical pathway. However, all the different players involved in the provision of services may have different interests and goals derived from their organizational structure and their role in the overall health system. This context of fragmented governance makes performance management of care services problematic. …

Chronic careService (systems architecture)Performance outcomesProcess managementDynamic performance managementPerformance managementbusiness.industryService delivery frameworkChronic care managementSystem dynamicsCollaborative Governance Chronic disease management programs Dynamic performance management Performance outcomes System Dynamics.Chronic disease management programClinical pathwaySettore SECS-P/07 - Economia AziendalePerformance outcomeChronic disease management programsHealth careBusinessCollaborative governanceCollaborative governance
researchProduct